Interferon regulatory factor 3 as key element of the interferon signature in plasmacytoid dendritic cells from systemic lupus erythematosus patients: Novel genetic associations in the Mexican mestizo population

Clinical and Experimental Immunology

Volumn 178, Issue 3, 2014, Pages 428-437

  Santana de Anda, K ^a   Gomez Martin D ^a   Monsivais Urenda, A E ^b   Salgado Bustamante, M ^b   Gonzalez Amaro R ^b   Alcocer Varela, J ^a  

^a INSTITUTO NACIONAL DE CIENCIAS MÉDICAS Y NUTRICIÓN SALVADOR ZUBIRÁN   (Mexico)

^b UNIVERSIDAD AUTÓNOMA DE SAN LUIS POTOSÍ   (Mexico)

Author keywords

Dendritic cells; Interferon; IRF3; Systemic lupus erythematosus

Indexed keywords

ALPHA INTERFERON; INTERFERON REGULATORY FACTOR; INTERFERON REGULATORY FACTOR 3; IRF3 PROTEIN, HUMAN; IRF5 PROTEIN, HUMAN;

ADULT; BLOOD; DENDRITIC CELL; FEMALE; GENETIC PREDISPOSITION; GENETICS; HUMAN; IMMUNOLOGY; MALE; PHOSPHORYLATION; PHYSIOLOGY; SINGLE NUCLEOTIDE POLYMORPHISM; SYSTEMIC LUPUS ERYTHEMATOSUS;

ADULT; DENDRITIC CELLS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; INTERFERON REGULATORY FACTOR-3; INTERFERON REGULATORY FACTORS; INTERFERON-ALPHA; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; PHOSPHORYLATION; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 84908674558     PISSN: 00099104     EISSN: 13652249     Source Type: Journal    
DOI: 10.1111/cei.12429     Document Type: Article

References (52)

1. Banchereau J, Briere F, Caux C etal. Immunobiology of dendritic cells. Annu Rev Immunol 2000; 18:767-811.
2. Liu YJ. IPC: professional type 1 interferon-producing cells and plasmacytoid dendritic cell precursors. Annu Rev Immunol 2005; 23:275-306.
3. Gottenberg JE, Chiocchia G. Dendritic cells and interferon-mediated autoimmunity. Biochimie 2007; 89:856-871.
4. Ytterberg SR, Schnitzer TJ. Serum interferon levels in patients with systemic lupus erythematosus. Arthritis Rheum 1982; 25:401-406.
5. Bennett L, Palucka AK, Arce E etal. Interferon and granulopoiesis signatures in systemic lupus erythematosus blood. J Exp Med 2003; 197:711-723.
6. Feng X, Wu H, Grossman JM etal. Association of increased interferon-inducible gene expression with disease activity and lupus nephritis in patients with systemic lupus erythematosus. Arthritis Rheum 2006; 54:2951-2962.
7. Kirou KA, Lee C, George S, Louca K, Peterson MG, Crow MK. Activation of the interferon-alpha pathway identifies a subgroup of systemic lupus erythematosus patients with distinct serologic features and active disease. Arthritis Rheum 2005; 52:1491-1503.
8. Kyogoku C, Tsuchiya N. A compass that points to lupus: genetic studies on type I interferon pathway. Genes Immun 2007; 8:445-455.
9. Niewold TB, Hua J, Lehman TJ, Harley JB, Crow MK. High serum IFN-alpha activity is a heritable risk factor for systemic lupus erythematosus. Genes Immun 2007; 8:492-502.
10. Forabosco P, Gorman JD, Cleveland C etal. Meta-analysis of genome-wide linkage studies of systemic lupus erythematosus. Genes Immun 2006; 7:609-614.
11. Han JW, Zheng HF, Cui Y etal. Genome-wide association study in a Chinese Han population identifies nine new susceptibility loci for systemic lupus erythematosus. Nat Genet 2009; 41:1234-1237.
12. Kim I, Kim YJ, Kim K etal. Genetic studies of systemic lupus erythematosus in Asia: where are we now? Genes Immun 2009; 10:421-432.
13. Kelly JA, Kelley JM, Kaufman KM etal. Interferon regulatory factor-5 is genetically associated with systemic lupus erythematosus in African Americans. Genes Immun 2008; 9:187-194.
14. Lee YH, Song GG. Association between the rs2004640 functional polymorphism of interferon regulatory factor 5 and systemic lupus erythematosus: a meta-analysis. Rheumatol Int 2009; 29:1137-1142.
15. Reddy MV, Velazquez-Cruz R, Baca V etal. Genetic association of IRF5 with SLE in Mexicans: higher frequency of the risk haplotype and its homozygozity than Europeans. Hum Genet 2007; 121:721-727.
16. Sanchez E, Webb RD, Rasmussen A etal. Genetically determined Amerindian ancestry correlates with increased frequency of risk alleles for systemic lupus erythematosus. Arthritis Rheum 2010; 62:3722-3729.
17. Feng D, Stone RC, Eloranta ML etal. Genetic variants and disease-associated factors contribute to enhanced interferon regulatory factor 5 expression in blood cells of patients with systemic lupus erythematosus. Arthritis Rheum 2010; 62:562-573.
18. Niewold TB, Kelly JA, Flesch MH, Espinoza LR, Harley JB, Crow MK. Association of the IRF5 risk haplotype with high serum interferon-alpha activity in systemic lupus erythematosus patients. Arthritis Rheum 2008; 58:2481-2487.
19. Rullo OJ, Woo JM, Wu H etal. Association of IRF5 polymorphisms with activation of the interferon alpha pathway. Ann Rheum Dis 2010; 69:611-617.
20. Akahoshi M, Nakashima H, Sadanaga A etal. Promoter polymorphisms in the IRF3 gene confer protection against systemic lupus erythematosus. Lupus 2008; 17:568-574.
21. Sanchez E, Gonzalez-Gay MA, Callejas-Rubio JL etal. No evidence for genetic association of interferon regulatory factor 3 in systemic lupus erythematosus. Lupus 2009; 18:230-234.
22. Hochberg MC. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1997; 40:1725.
23. Bombardier C, Gladman DD, Urowitz MB, Caron D, Chang CH. Derivation of the SLEDAI. A disease activity index for lupus patients. The Committee on Prognosis Studies in SLE. Arthritis Rheum 1992; 35:630-640.
24. Wagner EM. Monitoring gene expression: quantitative real-time rt-PCR. Methods Mol Biol 2013; 1027:19-45.
25. Fitzgerald KA, McWhirter SM, Faia KL etal. IKKepsilon and TBK1 are essential components of the IRF3 signaling pathway. Nat Immunol 2003; 4:491-496.
26. Salloum R, Niewold TB. Interferon regulatory factors in human lupus pathogenesis. Transl Res 2011; 157:326-331.
27. International Consortium for Systemic Lupus Erythematosus G, Harley JB, Alarcon-Riquelme ME, Criswell LA etal. Genome-wide association scan in women with systemic lupus erythematosus identifies susceptibility variants in ITGAM, PXK, KIAA1542 and other loci. Nat Genet 2008; 40:204-210.
28. Blomberg S, Eloranta ML, Magnusson M, Alm GV, Ronnblom L. Expression of the markers BDCA-2 and BDCA-4 and production of interferon-alpha by plasmacytoid dendritic cells in systemic lupus erythematosus. Arthritis Rheum 2003; 48:2524-2532.
29. Carvalheiro T, Rodrigues A, Lopes A etal. Tolerogenic versus inflammatory activity of peripheral blood monocytes and dendritic cells subpopulations in systemic lupus erythematosus. Clin Dev Immunol 2012; 2012:1-14.
30. Henriques A, Ines L, Carvalheiro T etal. Functional characterization of peripheral blood dendritic cells and monocytes in systemic lupus erythematosus. Rheumatol Int 2012; 32:863-869.
31. + (myeloid) dendritic cells in systemic lupus erythematosus. Clin Exp Immunol 2005; 142:84-91.
32. Jin O, Kavikondala S, Sun L etal. Systemic lupus erythematosus patients have increased number of circulating plasmacytoid dendritic cells, but decreased myeloid dendritic cells with deficient CD83 expression. Lupus 2008; 17:654-662.
33. Ding D, Mehta H, Mccune WJ, Kaplan MJ. Aberrant phenotype and function of myeloid dendritic cells in systemic lupus erythematosus. J Immunol 2006; 177:5878-5889.
34. Gerl V, Lischka A, Panne D etal. Blood dendritic cells in systemic lupus erythematosus exhibit altered activation state and chemokine receptor function. Ann Rheum Dis 2010; 69:1370-1377.
35. Zhang R, Xing M, Ji X etal. Interferon-alpha and interleukin-6 in SLE serum induce the differentiation and maturation of dendritic cells derived from CD34+ hematopoietic precursor cells. Cytokine 2010; 50:195-203.
36. Blanco P, Palucka AK, Gill M, Pascual V, Banchereau J. Induction of dendritic cell differentiation by IFN-alpha in systemic lupus erythematosus. Science 2001; 294:1540-1543.
37. Crispin JC, Vargas-Rojas MI, Monsivais-Urenda A, Alcocer-Varela J. Phenotype and function of dendritic cells of patients with systemic lupus erythematosus. Clin Immunol 2012; 143:45-50.
38. Decker P, Kotter I, Klein R, Berner B, Rammensee HG. Monocyte-derived dendritic cells over-express CD86 in patients with systemic lupus erythematosus. Rheumatology 2006; 45:1087-1095.
39. Dauer M, Obermaier B, Herten J etal. Mature dendritic cells derived from human monocytes within 48 hours: a novel strategy for dendritic cell differentiation from blood precursors. J Immunol 2003; 170:4069-4076.
40. Niewold TB, Kelly JA, Kariuki SN etal. IRF5 haplotypes demonstrate diverse serological associations which predict serum interferon alpha activity and explain the majority of the genetic association with systemic lupus erythematosus. Ann Rheum Dis 2012; 71:463-468.
41. Fu Q, Zhao J, Qian X etal. Association of a functional IRF7 variant with systemic lupus erythematosus. Arthritis Rheum 2011; 63:749-754.
42. Lin LH, Ling P, Liu MF. The potential role of interferon-regulatory factor 7 among Taiwanese patients with systemic lupus erythematosus. J Rheumatol 2011; 38:1914-1919.
43. Pons-Estel BA, Catoggio LJ, Cardiel MH etal., Grupo Latinoamericano de Estudio del L. The GLADEL multinational Latin American prospective inception cohort of 1214 patients with systemic lupus erythematosus: ethnic and disease heterogeneity among 'Hispanics'. Medicine 2004; 83:1-17.
44. Vila LM, Alarcon GS, McGwin G Jr etal., Group LS. Early clinical manifestations, disease activity and damage of systemic lupus erythematosus among two distinct US Hispanic subpopulations. Rheumatology 2004; 43:358-363.
45. Tada Y, Kondo S, Aoki S etal. Interferon regulatory factor 5 is critical for the development of lupus in MRL/lpr mice. Arthritis Rheum 2011; 63:738-748.
46. Moser KL, Neas BR, Salmon JE etal. Genome scan of human systemic lupus erythematosus: evidence for linkage on chromosome 1q in African-American pedigrees. Proc Natl Acad Sci USA 1998; 95:14869-14874.
47. Stetson DB, Medzhitov R. Recognition of cytosolic DNA activates an IRF3-dependent innate immune response. Immunity 2006; 24:93-103.
48. Szabo A, Gogolak P, Pazmandi K etal. The two-component adjuvant IC31(R) boosts type I interferon production of human monocyte-derived dendritic cells via ligation of endosomal TLRs. PLOS ONE 2013; 8:e55264.
49. Long L, Deng Y, Yao F etal. Recruitment of phosphatase PP2A by RACK1 adaptor protein deactivates transcription factor IRF3 and limits type I interferon signaling. Immunity 2014; 40:515-529.
50. Salloum R, Franek BS, Kariuki SN etal. Genetic variation at the IRF7/PHRF1 locus is associated with autoantibody profile and serum interferon-alpha activity in lupus patients. Arthritis Rheum 2010; 62:553-561.
51. Smith S, Gabhann JN, Higgs R etal. Enhanced interferon regulatory factor 3 binding to the interleukin-23p19 promoter correlates with enhanced interleukin-23 expression in systemic lupus erythematosus. Arthritis Rheum 2012; 64:1601-1609.
52. Espinosa A, Dardalhon V, Brauner S etal. Loss of the lupus autoantigen Ro52/Trim21 induces tissue inflammation and systemic autoimmunity by disregulating the IL-23-Th17 pathway. J Exp Med 2009; 206:1661-1671.